Latest Stories

G
Screener

1 Stock Under $50 with Exciting Potential and 2 We Brush Off

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.

Dec 12, 2025
C
Screener

3 Russell 2000 Stocks We Steer Clear Of

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.

Dec 12, 2025
A
Screener

2 Russell 2000 Stocks for Long-Term Investors and 1 We Find Risky

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.

Dec 12, 2025
S
Three Reasons

3 Reasons to Avoid SNEX and 1 Stock to Buy Instead

StoneX trades at $100.35 and has moved in lockstep with the market. Its shares have returned 17.9% over the last six months while the S&P 500 has gained 13.9%.

Dec 12, 2025
W
Three Reasons

2 Reasons to Like WCN and 1 to Stay Skeptical

Over the past six months, Waste Connections’s shares (currently trading at $171.55) have posted a disappointing 10.4% loss, well below the S&P 500’s 13.9% gain. This may have investors wondering how to approach the situation.

Dec 12, 2025
U
Three Reasons

3 Reasons U is Risky and 1 Stock to Buy Instead

Unity has been on fire lately. In the past six months alone, the company’s stock price has rocketed 97%, reaching $49.20 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

Dec 12, 2025
P
Three Reasons

3 Reasons to Sell PRVA and 1 Stock to Buy Instead

Privia Health has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 9.6% to $24.88 per share while the index has gained 13.9%.

Dec 12, 2025
N
Three Reasons

3 Reasons to Avoid NAVI and 1 Stock to Buy Instead

Over the last six months, Navient’s shares have sunk to $12.96, producing a disappointing 5.3% loss - a stark contrast to the S&P 500’s 13.9% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.

Dec 12, 2025
A
Three Reasons

Akamai Technologies (AKAM): Buy, Sell, or Hold Post Q3 Earnings?

While the S&P 500 is up 13.9% since June 2025, Akamai Technologies (currently trading at $85.26 per share) has lagged behind, posting a return of 8.6%. This may have investors wondering how to approach the situation.

Dec 12, 2025
A
Three Reasons

Allegion (ALLE): Buy, Sell, or Hold Post Q3 Earnings?

Allegion’s 19.2% return over the past six months has outpaced the S&P 500 by 5.3%, and its stock price has climbed to $165.31 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Dec 12, 2025